Article
Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges
15 Nov 2019
Abstract excerpt
Epigenome editing is a promising approach for both basic research and clinical application. With the convergence of techniques from different fields, regulating gene expression artificially becomes possible. From a clinical point of view, targeted epigenome editing by CRISPR/Cas9 of disease-related genes offers novel therapeutic avenues for many diseases. In this review, we summarize the EpiEffectors used in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
